Atom | Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R61/R33 Clinical Trial Required)

Funder: National Institutes of Health

Due Dates: February 7, 2025 (New/Renewal/Resubmission/Revision) | May 7, 2025 (AIDS) | November 5, 2025 (New) | January 7, 2026 (AIDS) | November 5, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: No set budget limit; typical direct costs up to $500,000/year; project period up to 5 years (1-year R61, up to 4-year R33 phase).

Summary: Supports implementation research to improve integrated, patient-centered care for non-communicable disease multimorbidity in low- and middle-income countries and US Tribal populations.

Key Information: Clinical trial required; both R61 (planning) and R33 (implementation) phases must be addressed; US applicants must include LMIC partners as key personnel.

Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R61/R33 Clinical Trial Required)

Sign in to see full grant listing